Day: September 8, 2022

In accordance with article 19 of Regulation (EU) No 596/2014, Solar is required to report share trading in Solar A/S of members of the Board of Directors, members of the Executive Board and related parties. The information in the below statement is based on reports from the above-mentioned persons to Solar.Name: Katrine BorumReason: Member of the Board of DirectorsSecurities ID: DK0010274844 Solar BTransaction type: Sale of sharesTransaction place: Nasdaq Copenhagen, DCSETransaction date: 6-8 September 2022Transaction volume: 8,117 sharesMarket price in DKK 4,669,905.50The shares have been sold to meet inheritance taxes and charges – see announcement 13 2022. CONTACT IR Director Dennis Callesen – tel. +45 29 92 18 11 FACTS ABOUT SOLAR Solar is a leading European sourcing and...

LIBERTY, Mo., Sept. 08, 2022 (GLOBE NEWSWIRE) — American colleges and universities have now begun their fall semesters. Students at 14 of those institutions are doing so with the help of scholarships from Ferrellgas (OTC:FGPR), a nationwide propane logistics company. Now in its 30th year, the Ferrellgas Scholarship Program provides scholarship funds to the dependent children of employees of Ferrellgas and its industry-leading Blue Rhino propane tank brand. To be eligible, applicants must demonstrate substantial academic capability, participate in school activities, and meet certain financial requirements.  “We are incredibly honored to help these future leaders pursue their academic goals,” said Brent Banwart, Vice President of Human Resources at Ferrellgas. “They have a great foundation for success, and we are...

MIAMI, FL, Sept. 08, 2022 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL) announced today that CEO Michael McConnell, will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference which is being held September 12th – 14th, 2022 at the Lotte New York Palace Hotel in New York City. The event will include virtual participation as well as in-person participation. Mr. McConnell will be presenting on Monday, September 12 at 2:30 pm. Investors who would like to access the live presentation may do so by logging in here, and through the Investors Page on the EzFill website located at www.ezfl.com. About EzFill EzFill is a leader in the fast-growing mobile fuel industry, with the largest market share in its home state of Florida. Its mission is to disrupt the gas station fueling...

REGULATED RELEASE INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SAAS OF AUGUST 31, 2022 (1) Paris – September 8, 2022 NUMBER OF SHARES AS OF AUGUST 31, 2022Date 08/31/2022Company name KlépierreTrading place Euronext Paris (Compartment A)Mnemonic LISymbols EPA:LI / LI:FP / LOIM.PAISIN FR0000121964Total number of shares 286,861,172Total number of voting rights  Number of theoretical voting rights(2) 286,861,172Number of exercisable voting rights(3)  285,463,851AGENDA  October 19, 2022 Business review for the first nine months of 2022 (after market close)INVESTOR RELATIONS CONTACTS    Paul Logerot, Group Head of IR and Financial Communications+33 (0)7 50 66 05 63 — paul.logerot@klepierre.comJulia Croissant, IR Officer+33 (0)7 88 77 40 37 — julia.croissant@klepierre.com    ABOUT...

Orion Corporation NOTIFICATION08.09.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 08.09.2022Date 08.09.2022  Exchange transaction Buy  Share class ORNBV  Amount 13,908    Average price/share 44.3848 EURHighest price/share 44.7500 EURLowest price/share 44.0400 EURTotal price 617,303.80   EUR     The shares held by Orion Corporation on 08.09.2022:  ORNBV 609,962  On behalf of Orion Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For more information, please contact: Olli Huotari, SVP, Corporate Functions, Orion Corporation tel. +358 10 426 3054AttachmentORION SBB 08092022

Dupixent® (dupilumab) late-breaking Phase 3 data at EADV 2022 showed significant improvements in signs and symptoms of prurigo nodularisNearly three times as many Dupixent patients experienced clinically meaningful reductions in itch and skin lesions at 24 weeks compared to placebo There are currently no approved medicines specifically indicated to treat prurigo nodularis; regulatory submissions for Dupixent are under Priority Review in the U.S. and under review in the European Union 22 Dupixent abstracts are being presented at the European Academy of Dermatology and Venereology (EADV) 2022 Congress across four dermatological diseases with underlying type 2 inflammationParis and Tarrytown, N.Y. September 8, 2022. Detailed positive results from the Phase 3 PRIME trial evaluating Dupixent® (dupilumab) in adults with uncontrolled prurigo...

Ålandsbanken Abp  Changes in company’s own shares08.09.2022 at 18:30 EET Ålandsbanken Abp: Acquisitions of own shares 08.09.2022Date 08.09.2022  ExchangeBourse trade   Nasdaq Helsinki Oy (XHEL)Buy  Share class ALBBV  Amount             400  Average price/share 31.2020 EURHighest price/share 31.6000 EURLowest price/share 30.9000 EURTotal price 12,480.80 EUR     The shares held by Ålandsbanken Abp on 08.09.2022:    ALBBV                    35,412  On behalf of Ålandsbanken Abp Skandinaviska Enskilda Banken AB (Publ) Antti Salakka                      Janne Tiihonen For more information, please contact: Peter Wiklöf, Managing Director and Chief Executive, Bank of...